Literature DB >> 20947246

Postoperative treatment and prognosis of patients with resected single brain metastasis: how useful are established prognostic scores?

Carsten Nieder1, Sabrina T Astner, Nikolaus H Andratschke, Kirsten Marienhagen.   

Abstract

OBJECTIVE: To evaluate postoperative prognosis and the performance of known prognostic scores in patients treated with surgical resection for single brain metastasis.
METHODS: We evaluated prognostic factors and five previously published prognostic scores in a group of 74 patients with single brain metastasis treated with surgery with or without immediate whole-brain radiotherapy (WBRT).
RESULTS: In multivariate analysis, good performance status, absence of extracranial metastases and primary tumor control were significantly associated with improved overall survival. Survival (median 10.8 months) was not significantly prolonged by immediate WBRT. Salvage treatment was necessary in 87% of patients without immediate WBRT. All five scores identified groups of patients with superior prognosis. The recursive partitioning analysis (RPA) classes, the graded prognostic assessment (GPA) score and the score developed by Rades et al. identified a poor prognosis group, but the numbers of poor prognosis patients were very small.
CONCLUSIONS: RPA and GPA appear to have the most utility in delineating exceptionally good or poor prognosis patients after resection of single brain metastasis, but this finding remains to be validated in a larger study population. Identification and validation of suitable prognostic scores hopefully will guide decision making regarding local treatment of solitary brain metastasis.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20947246     DOI: 10.1016/j.clineuro.2010.09.009

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  7 in total

1.  Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgery.

Authors:  Hideyuki Arita; Yoshitaka Narita; Yasuji Miyakita; Makoto Ohno; Minako Sumi; Soichiro Shibui
Journal:  J Neurooncol       Date:  2013-10-25       Impact factor: 4.130

2.  Surgery on motor area metastasis.

Authors:  Marta Rossetto; Pietro Ciccarino; Giuseppe Lombardi; Giuseppe Rolma; Diego Cecchin; Alessandro Della Puppa
Journal:  Neurosurg Rev       Date:  2015-07-17       Impact factor: 3.042

3.  A new survival score for patients with brain metastases from non-small cell lung cancer.

Authors:  D Rades; L Dziggel; B Segedin; I Oblak; V Nagy; A Marita; S E Schild; N T Trang; M T Khoa
Journal:  Strahlenther Onkol       Date:  2013-06-07       Impact factor: 3.621

4.  A simple survival score for patients with brain metastases from breast cancer.

Authors:  D Rades; L Dziggel; B Segedin; I Oblak; V Nagy; A Marita; S E Schild; N T Trang; M T Khoa
Journal:  Strahlenther Onkol       Date:  2013-06-07       Impact factor: 3.621

Review 5.  [Resecting hematogenous metastases: reasons against].

Authors:  F C Roos; J W Thüroff
Journal:  Urologe A       Date:  2014-06       Impact factor: 0.639

6.  The Choice of Local Treatment Modalities for Patients with Brain Metastases from Digestive Cancers.

Authors:  Jun Dong; Liyan Wu; Fang Wang; Jinsheng Huang; Pili Hu; Bei Zhang; Liang-Ping Xia
Journal:  J Oncol       Date:  2019-11-21       Impact factor: 4.375

7.  Epidemiology and prognosis of brain metastases.

Authors:  Keith J Stelzer
Journal:  Surg Neurol Int       Date:  2013-05-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.